A Study to Assess Absolute Bioavailability (ABA) of TAK-831 and to Characterize Mass Balance, Pharmacokinetics (PK), Metabolism, and Excretion of [14C]TAK-831 in Male Healthy Participants
Clinical trial NCT04234672 · COMPLETED
Trial details
- NCT number
- NCT04234672
- Sponsor
- Neurocrine Biosciences
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-17
- Primary completion
- 2020-04-04
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.